Stephen Rocamboli - Net Worth and Insider Trading

Stephen Rocamboli Net Worth

The estimated net worth of Stephen Rocamboli is at least $19,461 dollars as of 2024-11-07. Stephen Rocamboli is the Director of Esperion Therapeutics Inc and owns about 8,111 shares of Esperion Therapeutics Inc (ESPR) stock worth over $17,114. Stephen Rocamboli is also the Director of TFF Pharmaceuticals Inc and owns about 1,440 shares of TFF Pharmaceuticals Inc (TFFP) stock worth over $2,347. Details can be seen in Stephen Rocamboli's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen Rocamboli has not made any transactions after 2023-08-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Stephen Rocamboli

To

Stephen Rocamboli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen Rocamboli owns 3 companies in total, including TFF Pharmaceuticals Inc (TFFP) , VioQuest Pharmaceuticals Inc (VOQP) , and Esperion Therapeutics Inc (ESPR) .

Click here to see the complete history of Stephen Rocamboli’s form 4 insider trades.

Insider Ownership Summary of Stephen Rocamboli

Ticker Comapny Transaction Date Type of Owner
TFFP TFF Pharmaceuticals Inc 2023-08-15 director
VOQP VioQuest Pharmaceuticals Inc 2008-06-13 director & Secretary
ESPR Esperion Therapeutics Inc 2023-05-10 director

Stephen Rocamboli Latest Holdings Summary

Stephen Rocamboli currently owns a total of 2 stocks. Among these stocks, Stephen Rocamboli owns 8,111 shares of Esperion Therapeutics Inc (ESPR) as of May 10, 2023, with a value of $17,114 and a weighting of 87.94%. Stephen Rocamboli also owns 1,440 shares of TFF Pharmaceuticals Inc (TFFP) as of August 15, 2023, with a value of $2,347 and a weighting of 12.06%.

Latest Holdings of Stephen Rocamboli

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ESPR Esperion Therapeutics Inc 2023-05-10 8,111 2.11 17,114
TFFP TFF Pharmaceuticals Inc 2023-08-15 1,440 1.63 2,347

Holding Weightings of Stephen Rocamboli


Stephen Rocamboli Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen Rocamboli has made a total of 1 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 8,111 shares on May 10, 2023, which cost Stephen Rocamboli around $12,167.

According to the SEC Form 4 filings, Stephen Rocamboli has made a total of 5 transactions in TFF Pharmaceuticals Inc (TFFP) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in TFF Pharmaceuticals Inc is the acquisition of 800 shares on August 15, 2023, which cost Stephen Rocamboli around $5,000.

Insider Trading History of Stephen Rocamboli

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen Rocamboli Trading Performance

GuruFocus tracks the stock performance after each of Stephen Rocamboli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen Rocamboli is -11.81%. GuruFocus also compares Stephen Rocamboli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen Rocamboli within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stephen Rocamboli's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stephen Rocamboli

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.51 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.03 LIMIT LIMIT LIMIT LIMIT LIMIT

Stephen Rocamboli Ownership Network

Ownership Network List of Stephen Rocamboli

No Data

Ownership Network Relation of Stephen Rocamboli

Insider Network Chart

Stephen Rocamboli Owned Company Details

What does TFF Pharmaceuticals Inc do?

Who are the key executives at TFF Pharmaceuticals Inc?

Stephen Rocamboli is the director of TFF Pharmaceuticals Inc. Other key executives at TFF Pharmaceuticals Inc include 10 percent owner Carlson Capital L P , 10 percent owner Clint Duane Carlson , and 10 percent owner Double Black Diamond Offshore Ltd .

TFF Pharmaceuticals Inc (TFFP) Insider Trades Summary

Over the past 18 months, Stephen Rocamboli made 1 insider transaction in TFF Pharmaceuticals Inc (TFFP) with a net purchase of 20,000. Other recent insider transactions involving TFF Pharmaceuticals Inc (TFFP) include a net purchase of 600,000 shares made by Harlan F Weisman , a net sale of 216,000 shares made by Carlson Capital L P , and a net purchase of 120,000 shares made by Zamaneh Mikhak .

In summary, during the past 3 months, insiders sold 0 shares of TFF Pharmaceuticals Inc (TFFP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,640 shares of TFF Pharmaceuticals Inc (TFFP) were sold and 32,800 shares were bought by its insiders, resulting in a net purchase of 24,160 shares.

TFF Pharmaceuticals Inc (TFFP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TFF Pharmaceuticals Inc Insider Transactions

No Available Data

Stephen Rocamboli Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen Rocamboli. You might contact Stephen Rocamboli via mailing address: C/oparmount Capital, 787 Seventh Ave 48th Fl, New York Ny 10019.